Research
According to a new study, the number of deaths worldwide due to ischaemic stroke is set to increase to nearly 5 million by 2030. During a period of 29 years between 1990 and 2019, the cases of death from ischaemic stroke leaped from 2 million to more than 3 million. The study, published in Neurology, [...]
NR Times reports on the much-anticipated trial of ALS treatment AMX0035, in an interview with Machelle Manuel, head of global medical affairs at its creator Amylyx.
Recently approved for treating ALS in the US, AMX0035 is now the subject of a major phase 3 clinical trial taking place across the US and Europe. ALS is a relentlessly progressive and fatal neurodegenerative disorder that up until recent decades was thought to be impossible to treat. While the cause of the condition is still uncertain, a new wave of treatments is coming to the fore. Sign up to NR Times to read our interview in full.Experts from the European Society of Cardiology (ESC) have urged women to get a simple health check-up in order to help prevent their risk of stroke. The experts say that all women should know their blood pressure. ESC spokesperson Professor Angela Maas, says: “Cardiovascular disease is the leading cause of death in women. “The risk [...]
A new study which examined over 420,000 adults in the UK has shown that those living with established cardiovascular disease and obesity are at a much higher risk of stroke and dying prematurely. The study also finds that these individuals also have considerably higher healthcare costs than those living with obesity without cardiovascular disease. Joint [...]
A new study has identified new potential pathway that could help improve sensory and motor functions post-stroke. Ischaemic stroke is caused by a blockage of blood flow to the brain. Treatments are urgently required in order to improve patient outcomes, as recovery currently relies largely on the timely injection of a blood clot-dissolving drug. Priorities [...]
As medical director of Holy Name’s renowned MS Center in New Jersey, Dr Mary Ann Picone is a hugely influential figure in the movement to advance MS treatments. NR Times speaks to her about challenges, opportunities and new developments in the MS field. Not so long ago, being diagnosed with MS meant an end to life as you knew it. So bleak was the outlook, recalls Dr Mary Ann Picone, that America’s MS community came up with a phrase soaked in gallows humour – “diagnose and adios”. Although as recently as the 1980s there were virtually no treatment options for clinicians to turn to, however, there are now numerous; and Dr Picone, who has been on the frontline of MS drug development in the decades since, has played an important role in helping to drive this. Read on to find out about the emerging therapies that will shape MS treatment in the coming years and Dr Picone's views on the road ahead in MS research.
New research has displayed the importance of physical activity in making a successful recovery after stroke. Those who spend four or more hours a week exercising after their stroke achieve better functional recovery within six months than those who do not. The study, published in the scientific journal JAMA Network Open, is based on data concerning [...]
New research focusing on the relationship between stroke and air pollution has uncovered what effects air pollution has on our brain health. Air pollution has previously been shown to have a negative effect on the prognosis of ischemic stroke, or stroke caused by reduced blood flow to the brain, however, the exact mechanism has remained [...]
According to a new study involving 6.5 million individuals, young adults in their 20s and 30s with mental health disorders are up to three times as likely to have a stroke. Researchers found that lifestyle behaviours did not explain this excess risk. 1 in 8 of the 20-to-39-year-old participants had a form of mental illness, [...]
Stroke continues to be a major cause of mortality across the world, however, researchers believe they have found a new target for treating stroke. Vascular smooth muscle cell (VSMC) activation plays a crucial role in the development of multiple vascular diseases, including stroke. In this new study, researchers found that when fragile-X related protein-1 (FXR1) [...]
